{"id":1654582,"date":"2025-05-03T17:00:41","date_gmt":"2025-05-03T19:00:41","guid":{"rendered":"https:\/\/teknomers.com\/fr\/novo-nordisk-triomphe-avec-wegovy-aux-etats-unis\/"},"modified":"2025-05-03T17:00:46","modified_gmt":"2025-05-03T19:00:46","slug":"novo-nordisk-triomphe-avec-wegovy-aux-etats-unis","status":"publish","type":"post","link":"https:\/\/teknomers.com\/fr\/novo-nordisk-triomphe-avec-wegovy-aux-etats-unis\/","title":{"rendered":"Novo Nordisk triomphe avec Wegovy aux \u00c9tats-Unis"},"content":{"rendered":"<p> <br \/>\n<\/p>\n<p>La FDA de l&#8217;Autorit\u00e9 sanitaire des \u00c9tats-Unis a accept\u00e9 une demande de Novo Nordisk pour une nouvelle application de la pilule Wegovy, comme l&#8217;a annonc\u00e9 la soci\u00e9t\u00e9 pharmaceutique danoise.<\/p>\n<div>\n<p>Wegovy pourrait ainsi devenir le premier m\u00e9dicament oral GLP 1 pour la r\u00e9gulation du poids chronique et pour traiter l&#8217;ob\u00e9sit\u00e9. La date limite de la FDA pour la d\u00e9cision sur la demande est attendue au quatri\u00e8me trimestre, a poursuivi Novo Nordisk. <\/p>\n<p>  Dow Jones<\/p>\n<\/div>\n<p><br \/>\n<br \/><a href=\"https:\/\/www.finanzen.net\/nachricht\/aktien\/glp-1-medikament-novo-nordisk-triumphiert-mit-wegovy-in-den-usa-14445778\" rel=\"nofollow noopener\" target=\"_blank\">ttn-fr-28<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>La FDA de l&#8217;Autorit\u00e9 sanitaire des \u00c9tats-Unis a accept\u00e9 une demande de Novo Nordisk pour une nouvelle application de la pilule Wegovy, comme l&#8217;a annonc\u00e9 la soci\u00e9t\u00e9 pharmaceutique danoise. Wegovy pourrait ainsi devenir le premier m\u00e9dicament oral GLP 1 pour la r\u00e9gulation du poids chronique et pour traiter l&#8217;ob\u00e9sit\u00e9. La date limite de la FDA [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":1532514,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[507,84,3118,145338,145337,9561,121188],"class_list":["post-1654582","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-finance","tag-aux","tag-avec","tag-etatsunis","tag-nordisk","tag-novo","tag-triomphe","tag-wegovy"],"_links":{"self":[{"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/posts\/1654582","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/comments?post=1654582"}],"version-history":[{"count":0,"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/posts\/1654582\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/media\/1532514"}],"wp:attachment":[{"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/media?parent=1654582"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/categories?post=1654582"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/tags?post=1654582"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}